casoxin C [1666]



casoxin C


SMILES CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C(C)C
InChIKey FLMZYYASMMUDFC-FJKDSYQFSA-N
Sequence YIPIQYVLSR
HELM PEPTIDE1{Y.I.P.I.Q.Y.V.L.S.R}$$$$

Chemical Properties

Hydrogen bond acceptors 16
Hydrogen bond donors 16
Rotatable bonds 37
Log P -1.730
Molecular weight (Da) 1250.7
Stereochemistry info partial

Database connections

Model (AF2) C3a


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

casoxin C


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) C3a


Compound is not listed as a drug.